Extranodal Natural Killer (NK)/T-Cell Lymphoma Causing Severe Facial Destruction Refractory to Chemotherapy and Immunotherapy

By afschroeder • March 31, 2026

Tiu RA, Garcia JF. Extranodal Natural Killer (NK)/T-Cell Lymphoma Causing Severe Facial Destruction Refractory to Chemotherapy and Immunotherapy. Cureus. 2026 Feb 25;18(2):e104253. doi: 10.7759/cureus.104253. PMID: 41909399; PMCID: PMC13030932.

Tags: DGSOM Student, ebv-associated lymphoma, epstein-barr virus, extranodal natural killer/t-cell lymphoma, General Internal Medicine, Hospitalist, nasal type, non-hodgkin’s lymphomas, pembrolizumab with chemotherapy, Publications

Evaluating selected gene therapies for cardiovascular diseases: an updated scoping review and evidence map of randomised controlled trials

Apaydin EA, Richard J, Miner SA, Waymouth M, Roberts D, Vockley J, Richardson AS. Evaluating selected gene therapies for cardiovascular diseases: an updated scoping review[...]

Primary intestinal lymphangiectasia across the lifespan: adult-pediatric comparisons of diagnostic delay, immune findings, and treatment patterns

Stirrat T, Solanky P, Thiru S, Singh L, Mehta S, Kanth P. Primary intestinal lymphangiectasia across the lifespan: adult-pediatric comparisons of diagnostic delay, immune findings,[...]

Interdisciplinary Weight Management in a Safety-Net Health System: A Pilot Implementation Study

DeCan C, Thure K, Pedley N, Cervantes B, Camargo O, Fing Castro K, Cabral J, Gallardo M, Rodriguez Reyes D, Perez A, Young S, Nafisi[...]